Eosinophilic esophagitis (EoE) is a chronic esophageal disease caused by immune system reaction and is clinically characterized by the symptoms of esophageal dysfunction and histologically characterized by an inflammatory process in which eosinophils dominate (
1,
2). The EoE is caused by an abnormal immunologic response to specific antigens. Food antigens are the most common allergens responsible for EoE, and respiratory antigens are in second place (
3). The prevalence of the disease is rising (
4,
5), and EoE is the second most common cause of chronic esophagitis (
6). The disease could occur at any age. Almost 75% of the patients are male, and the mean age of children is 8 - 10 years (
7). Up to 50% of patients are affected by other allergic diseases, such as asthma, eczema, or allergic rhinitis (
8). The clinical manifestations of EoE differ by age. Among adults and teens, the disease may emerge as dysphagia and food impaction. In younger children, it represents eating disorders which could be abnormal eating patterns (e.g., only drinking liquids or eating soft foods), gaining adaptive habits (e.g., refusing solid foods which have already been eaten, eating slowly, over-chewing, over-drinking liquids with meals), failure to thrive or reflux symptoms (e.g., vomit, regurgitation, water brash, epigastric pain, heartburn, and chest pain) (
9).
In patients with esophageal dysfunction and endoscopic findings in favor of EoE who have eosinophil predominance in the biopsy, EoE is confirmed. Mucosal eosinophilia must be observed without other causes, such as infections and medications (
10,
11). EoE treatment is based on identifying and eliminating dietary antigens, while topical steroids given by metered dose inhaler (MDI) or swallowing a viscous solution are effective therapeutic options (
12). Short-course systemic steroids and biologic treatments, such as Reslizumab and Mepolizumab, are rarely used (
13).
A comprehensive literature review showed that in infants and children, unlike adults, ultrasound has a high sensitivity of 87% and an average specificity of 63% compared to the gold standard of a 24-hour pH-monitoring test for GERD diagnosis (
14). Unfortunately, the only definite approach currently available to evaluate disease activity is endoscopy with biopsy, and it is necessary to perform the procedure several times for each patient, which would cause costs and potential complications (
15). This study investigated the possibility of replacing a non-invasive method with standard invasive methods, such as endoscopy.